Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Aug 17, 2021
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc.
| 3.09K |
$17.12 | -$24,085.03 | +6.95% | 47.61K |
Aug 13 - Aug 17
| |||||||
Travere Therapeutics, Inc.
| -1.25K |
$13.81 | -$17,262.50 | -2.73% | 44.52K |
Jul 28
|
Scheduled
| ||||||
Travere Therapeutics, Inc.
| -750.00 |
$19.30 | -$14,475.00 | -1.62% | 45.59K |
May 11 - May 12
|
Scheduled
| ||||||
Travere Therapeutics, Inc.
| -2.25K |
$31.50 | -$70,863.75 | -4.63% | 46.34K |
Feb 5 - Feb 8
|
Scheduled
| ||||||
Travere Therapeutics, Inc.
| 4.5K |
—
|
—
| +10.21% | 48.59K |
Feb 3
| |||||||
Travere Therapeutics, Inc.
| -1.81K |
$28.91 | -$52,413.83 | -3.95% | 44.09K |
Feb 3
|
Scheduled
| ||||||
Travere Therapeutics, Inc.
| 3.19K |
$30.75 | -$55,749.75 | +7.46% | 45.91K |
Jan 31 - Feb 2
|
Scheduled
| ||||||
Travere Therapeutics, Inc.
| 15K |
—
|
—
| +54.11% | 42.72K |
Jan 21
| |||||||
Retrophin, Inc.
| -750.00 |
$18.48 | -$13,860.00 | -2.65% | 27.55K |
Sep 23
|
Scheduled
| ||||||
Retrophin, Inc.
| 2.25K |
$18.59 | -$13,942.50 | +8.64% | 28.3K |
Sep 18 - Sep 22
|
Scheduled
| ||||||
Retrophin, Inc.
| -870.00 |
$20.49 | -$17,826.30 | -3.23% | 26.05K |
Jul 28
| |||||||
Retrophin, Inc.
| -527.00 |
$16.98 | -$8,950.73 | -1.93% | 26.73K |
May 12
| |||||||
Retrophin, Inc.
| 3.21K |
$15.36 | -$27,487.24 | +13.35% | 27.25K |
Mar 5
| |||||||
Retrophin, Inc.
| 9K |
—
|
—
| +66.67% | 22.5K |
Jan 31
| |||||||
Retrophin, Inc.
| -2.50K |
$19.95 | -$49,862.50 | -15.63% | 13.5K |
Jul 30 - Jul 31
|
Scheduled
| ||||||
Retrophin, Inc.
| 6K |
—
|
—
| +60.00% | 16K |
May 9
| |||||||
Retrophin, Inc.
| 10K |
—
|
—
|
∞
| 10K |
Jul 26
| |||||||
Retrophin, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Esperion Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 23
| |||||||
Esperion Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.